©The Author(s) 2026.
World J Gastroenterol. Jan 14, 2026; 32(2): 114097
Published online Jan 14, 2026. doi: 10.3748/wjg.v32.i2.114097
Published online Jan 14, 2026. doi: 10.3748/wjg.v32.i2.114097
Table 6 Clinical utilities of the fibrosis-4 and type IV collagen 7S (radioimmunoassay) for the diagnosis of fibrosis stages 2 and 3 or higher[17]
| Cutoff value | PPV | NPV | Sensitivity | Specificity | FN | FP | ||
| FIB-4 index | Low | 1.30 | 0.257 | 0.962 | 0.892 | 0.513 | 0.108 | 0.487 |
| High | 2.67 | 0.382 | 0.093 | 0.547 | 0.833 | 0.453 | 0.167 | |
| COL4-7S (ng/mL), F0-1 vs F2-4) | Low | 3.8 | 0.541 | 0.842 | 0.902 | 0.405 | 0.098 | 0.595 |
| High | 6.0 | 0.775 | 0.676 | 0.446 | 0.900 | 0.554 | 0.100 | |
| FIB-4 and COL4-7S | 1.3 and 3.8 | 0.690 | 0.792 | 0.752 | 0.737 | 0.248 | 0.263 | |
| COL4-7S, F0-2 vs F3-4 | Low | 4.8 | 0.315 | 0.969 | 0.892 | 0.634 | 0.108 | 0.366 |
| High | 6.8 | 0.530 | 0.081 | 0.576 | 0.904 | 0.424 | 0.096 | |
| FIB-4 and COL4-7S (ng/mL) | 1.3 and 4.8 | 0.366 | 0.953 | 0.806 | 0.737 | 0.194 | 0.263 | |
| F0-1 vs F2-4 | 1.3 and 4.3 | 0.706 | 0.787 | 0.730 | 0.766 | 0.270 | 0.234 | |
| F0-2 vs F3-4 | 1.3 and 4.3 | 0.307 | 0.963 | 0.871 | 0.630 | 0.129 | 0.370 |
- Citation: Kamada Y, Sumida Y, Takahashi H, Ishiba H, Kawanaka M, Tada T, Yoneda M, Imajo K, Seko Y, Fujii H, Nakajima A. Noninvasive strategies for metabolic dysfunction-associated steatotic liver disease assessment and referral in Japan. World J Gastroenterol 2026; 32(2): 114097
- URL: https://www.wjgnet.com/1007-9327/full/v32/i2/114097.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i2.114097